Marty Mayo

Affiliations reported with papers

Linked publications

Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer 2020

A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer 2018

Related research

FOLR1-anchored DR5 bispecific antibody

TRIM37 in breast-cancer outcomes